Literature DB >> 17904218

Cholecystokinin enhances GABAergic inhibitory transmission in basolateral amygdala.

L Chung1, S D Moore.   

Abstract

The neuropeptide cholecystokinin (CCK) is anxiogenic in studies of human and animal behavior. As the amygdala formation has been implicated in generation of emotional states such as anxiety, we tested the effect of CCK on spontaneous synaptic events in the basolateral amygdala (BLA) using whole cell patch recordings in rat brain slice preparation. We found that CCK increased the frequency of spontaneous inhibitory postsynaptic potentials (sIPSPs) and currents (sIPSCs). This effect was blocked by the fast sodium channel blocker tetrodotoxin (TTX), indicating that the CCK effect is likely mediated by direct excitation of GABAergic interneurons. The CCK(B) receptor subtype antagonist, CR2945, blocked the CCK effect, while CCK4, a specific CCK(B) agonist, increased sIPSC frequency. We hypothesize that these actions may underlie the anxiogenic effects of CCK observed in behavioral studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904218     DOI: 10.1016/j.npep.2007.08.001

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  16 in total

1.  Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala.

Authors:  Florence P Varodayan; Michal Bajo; Neeraj Soni; George Luu; Samuel G Madamba; Paul Schweitzer; Marisa Roberto
Journal:  Addict Biol       Date:  2016-01-20       Impact factor: 4.280

2.  Brain expression and song regulation of the cholecystokinin gene in the zebra finch (Taeniopygia guttata).

Authors:  Peter V Lovell; Claudio V Mello
Journal:  J Comp Neurol       Date:  2011-02-01       Impact factor: 3.215

Review 3.  Cholecystokinin: a multi-functional molecular switch of neuronal circuits.

Authors:  Soo Yeun Lee; Ivan Soltesz
Journal:  Dev Neurobiol       Date:  2011-01-01       Impact factor: 3.964

4.  Haploinsufficiency in peptidylglycine alpha-amidating monooxygenase leads to altered synaptic transmission in the amygdala and impaired emotional responses.

Authors:  Eric D Gaier; Ramona M Rodriguiz; Xin-Ming M Ma; Shobhana Sivaramakrishnan; Danielle Bousquet-Moore; William C Wetsel; Betty A Eipper; Richard E Mains
Journal:  J Neurosci       Date:  2010-10-13       Impact factor: 6.167

5.  Genetical genomic determinants of alcohol consumption in rats and humans.

Authors:  Boris Tabakoff; Laura Saba; Morton Printz; Pam Flodman; Colin Hodgkinson; David Goldman; George Koob; Heather N Richardson; Katerina Kechris; Richard L Bell; Norbert Hübner; Matthias Heinig; Michal Pravenec; Jonathan Mangion; Lucie Legault; Maurice Dongier; Katherine M Conigrave; John B Whitfield; John Saunders; Bridget Grant; Paula L Hoffman
Journal:  BMC Biol       Date:  2009-10-27       Impact factor: 7.431

6.  Cholecystokinin action on layer 6b neurons in somatosensory cortex.

Authors:  Leeyup Chung; Scott D Moore; Charles L Cox
Journal:  Brain Res       Date:  2009-06-02       Impact factor: 3.252

7.  Differential activation of neuronal cell types in the basolateral amygdala by corticotropin releasing factor.

Authors:  Amanda B Rostkowski; Randy J Leitermann; Janice H Urban
Journal:  Neuropeptides       Date:  2013-05-18       Impact factor: 3.286

8.  Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention.

Authors:  Mallory E Bowers; Kerry J Ressler
Journal:  Neuropsychopharmacology       Date:  2014-09-01       Impact factor: 7.853

9.  Cell-specific expression of neuropeptide Y Y1 receptor immunoreactivity in the rat basolateral amygdala.

Authors:  Amanda B Rostkowski; Tara L Teppen; Daniel A Peterson; Janice H Urban
Journal:  J Comp Neurol       Date:  2009-11-10       Impact factor: 3.215

10.  Cholecystokinin Switches the Plasticity of GABA Synapses in the Dorsomedial Hypothalamus via Astrocytic ATP Release.

Authors:  Karen M Crosby; Ciaran Murphy-Royal; Sarah A Wilson; Grant R Gordon; Jaideep S Bains; Quentin J Pittman
Journal:  J Neurosci       Date:  2018-08-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.